These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1103241)

  • 1. [Prevention of hyperacute active rejection of renal allografts in primates using F(ab')2 and adequate immunosuppression].
    Martins AC; Wren SF; Busch GJ; MacPherson SG; von Haefen U; Wilson RE
    AMB Rev Assoc Med Bras; 1975 Sep; 21(9):259-64. PubMed ID: 1103241
    [No Abstract]   [Full Text] [Related]  

  • 2. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
    Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
    Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of humoral rejection of renal allografts in presensitized monkeys by monospecific F(ab')2 fragments.
    Kahan MG; Martins AC; Macpherson SG; Wren SF; Busch GJ; Wilson RE
    Surg Forum; 1975; 26():311-3. PubMed ID: 814638
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical attempt to avoid hyperacute rejection by F (ab') 2 organ pretreatment.
    Ahlmén J; Gustafsson A; Claes G; Kaijser B; Svalander C; Gelin L
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):51-2. PubMed ID: 781817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of canine renal allografts after treatment with polyspecific F(ab')2 fragments.
    Abouna GM; Garver FA; Kogure H; DeLong TG; Andres GA
    Surg Forum; 1973; 24():318-20. PubMed ID: 4618655
    [No Abstract]   [Full Text] [Related]  

  • 6. The renal xenograft rejection. Effect of hyperimmune F(ab') 2 and succinylated IgG.
    Habal MB; Misra MK; Busch GJ; Carpenter CB; Birtch AG
    Transplantation; 1972 Dec; 14(6):796-8. PubMed ID: 4566275
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

  • 8. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 9. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
    Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
    Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent glomerulonephritis due to anti-glomerular basement membrane-antibodies in two successive allografts.
    Beleil OM; Coburn JW; Shinaberger JH; Glassock RJ
    Clin Nephrol; 1973; 1(6):377-80. PubMed ID: 4594999
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary results with passive enhancement in human kidney transplantation.
    Solheim BG; Flatmark A; Thorsby E
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):53-8. PubMed ID: 781818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment.
    Corman JL; Kashiwagi N; Porter KA; Andres G; Iwatsuki S; Putnam CW; Popovtzer M; Penn I; Starzl TE
    Transplantation; 1973 Jul; 16(1):60-3. PubMed ID: 4576857
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal transplantation between 33 HL-A-identical siblings.
    Descamps B; Hinglais N; Crosnier J
    Transplant Proc; 1973 Mar; 5(1):231-6. PubMed ID: 4266652
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats.
    Yagyu K; Takeshita M; Otsuka T; Kubota H; Furuse A; van Breda Vriesman PJ
    Transplant Proc; 1994 Aug; 26(4):2343-4. PubMed ID: 8066768
    [No Abstract]   [Full Text] [Related]  

  • 16. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
    Holter AR; McKearn TJ; Neu MR; Stuart FP
    Surg Forum; 1972; 23(0):280-1. PubMed ID: 4601088
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 19. New perspectives on pathogenesis and treatment of rejection in kidney transplantation.
    Merrill JP
    Kidney Int Suppl; 1975 Feb; (3):318-22. PubMed ID: 1099311
    [No Abstract]   [Full Text] [Related]  

  • 20. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
    Holter AR; Neu MR; McKearn TJ; Lynch AF; Stuart FP
    Transplant Proc; 1973 Mar; 5(1):593-6. PubMed ID: 4121180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.